Biomarkers & Labeling reagents
Biomarkers include tools and technologies that can aid in understanding the prediction, cause, diagnosis, progression, regression, or outcome of treatment of disease. The application of biomarkers in the diagnosis and management of cardiovascular disease, infections, immunological and genetic disorders, and cancer are well known. Their use in research has grown out of the need to have a more direct measurement of exposures in the causal pathway of disease that is free from recall bias, and that can also have the potential of providing information on the absorption and metabolism of the exposures. Molecular biomarkers will, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of various diseases with obvious applications in analytic epidemiology, clinical trials and disease prevention, diagnosis, and disease management[1].
[1] R. Mayeux. Biomarkers: Potential Uses and Limitations. NeuroRx. 2004, 1, 182-188.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
3419 | 5-Bromo-2’-deoxyuridine | Thymidine analog; Labeling agent of cell proliferation | €50.00 | |
2256 | Biotinyl-phenylboronic acid | Biotinylated arylboronic acid for bio-orthogonal chemistry | €95.00 | |
2494 | D-Luciferin | Natural substrate of firefly luciferase. Compound for bioluminescence imaging (BLI) | €95.00 | |
2257 | Dansyl-PEG-phenylboronic acid | Dansylamide functionalized PEG-phenylboronic acid; Protein labeling reagent | €120.00 | |
2655 | Di-8-ANEPPS | Potentiometric fluorescent dye | €160.00 | |
2756 | Fluorescent probe QG-1 | Reversible labeling agent of glutathione (Fluorescent) | €125.00 | |
3355 | IDT307 | DAT/NET/SERT substrate; Fluorescent dye | €90.00 | |
2876 | MSTP | Thiol blocking reagent | €105.00 |